4-CHLORO-6-METHOXY-2-(METHYLSULFANYL)-5-NITROPYRIMIDINE, 95.0%, 250mg

4-n-Propoxy-3,5-dimethylbenzyl alcohol, 97.0%, 1g

2-[4-(2-Benzimidazolyl)phenyl]-4-phenylthiazole, 5g

tert-Butyl (2-chloro-5-(trifluoromethyl)pyridin-3-yl)carbamate, 97%, 100mg

acridine-9-carbaldehyde, 95.0%, 1g

Phase contrast Abbe condenser with slide for Plan PLPHi 20/S100 phase contrast infinity corrected objectives, slide with 20 and 100x phases, telescope and green filter

(5-Chloro-6-oxo-1,6-dihydropyridin-3-yl)boronic acid, 97%, 250mg

4-((tert-Butoxycarbonyl)amino)-1-methyl-1H-pyrazole-3-carboxylic acid, 98%, 100mg

1H-Imidazole, 2,4,5-tribromo-1-[[2-(trimethylsilyl)ethoxy]methyl]-, 98%, 5g

2,4-Dichloro-1-(4-chloro-2-methoxyphenoxy)benzene, 97.0%, 250mg

2-Fluoro-3-methoxypyridine, 95.0%, 5g

Na-[2,4-Dinitro-5-fluorophenyl]-L-valine amide, 95.0%, 1g

N-(4-(4-(Trifluoromethoxy)phenyl)pyrimidin-2-yl)-1H-indazol-5-amine, 98+%, 1mg